Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lisuride plus selegiline in the treatment of early Parkinson's disease.
Nappi G, Martignoni E, Horowski R, Pacchetti C, Rainer E, Bruggi P, Runge I. Nappi G, et al. Among authors: horowski r. Acta Neurol Scand. 1991 Jun;83(6):407-10. doi: 10.1111/j.1600-0404.1991.tb03973.x. Acta Neurol Scand. 1991. PMID: 1909485 Clinical Trial.
Antagonist effect of terguride in Parkinson's disease.
Ruggieri S, Stocchi F, Baronti F, Viselli F, Horowski R, Lucarelli C, Agnoli A. Ruggieri S, et al. Among authors: horowski r. Clin Neuropharmacol. 1991 Oct;14(5):450-6. doi: 10.1097/00002826-199110000-00010. Clin Neuropharmacol. 1991. PMID: 1683813 Clinical Trial.
Suppression of puerperal lactation by terguride. A double-blind study.
Venturini PL, Horowski R, Fasce V, Valenzano M, Ferreri C, Badino G, Rainer E, Scholz A, De Cecco L. Venturini PL, et al. Among authors: horowski r. Gynecol Obstet Invest. 1988;26(1):33-8. doi: 10.1159/000293669. Gynecol Obstet Invest. 1988. PMID: 3049266 Clinical Trial.
Lisuride in the treatment of parkinsonism.
McDonald RJ, Horowski R. McDonald RJ, et al. Among authors: horowski r. Eur Neurol. 1983;22(4):240-55. doi: 10.1159/000115567. Eur Neurol. 1983. PMID: 6884394
Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis.
Hofmann C, Penner U, Dorow R, Pertz HH, Jähnichen S, Horowski R, Latté KP, Palla D, Schurad B. Hofmann C, et al. Among authors: horowski r. Clin Neuropharmacol. 2006 Mar-Apr;29(2):80-6. doi: 10.1097/00002826-200603000-00005. Clin Neuropharmacol. 2006. PMID: 16614540
89 results